Washington Trust Advisors, Inc. Haemonetics Corp Transaction History
Washington Trust Advisors, Inc.
- $1.06 Billion
- Q2 2024
A detailed history of Washington Trust Advisors, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 102 shares of HAE stock, worth $8,058. This represents 0.0% of its overall portfolio holdings.
Number of Shares
102
Previous 102
-0.0%
Holding current value
$8,058
Previous $8,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HAE
# of Institutions
337Shares Held
55.2MCall Options Held
383KPut Options Held
45.1K-
Capital Research Global Investors Los Angeles, CA6.92MShares$546 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$471 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$406 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$303 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY3.83MShares$303 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.05B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...